119 related articles for article (PubMed ID: 29100787)
1. Facility Volume and Survival in Nasopharyngeal Carcinoma.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
[TBL] [Abstract][Full Text] [Related]
2. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
3. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
5. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
Haque W; Verma V; Butler EB; Teh BS
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
[TBL] [Abstract][Full Text] [Related]
7. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
8. The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
Goshtasbi K; Abiri A; Lehrich BM; Haidar YM; Tjoa T; Kuan EC
Head Neck; 2021 Sep; 43(9):2755-2763. PubMed ID: 33998094
[TBL] [Abstract][Full Text] [Related]
9. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract][Full Text] [Related]
10. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
[TBL] [Abstract][Full Text] [Related]
11. Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma.
Go RS; Bartley AC; Crowson CS; Shah ND; Habermann EB; Holton SJ; Holmes DR
J Clin Oncol; 2017 Feb; 35(6):598-604. PubMed ID: 28199819
[TBL] [Abstract][Full Text] [Related]
12. The association between facility volume and overall survival in patients with Merkel cell carcinoma.
Yoshida EJ; Luu M; Freeman M; Essner R; Gharavi NM; Shiao SL; Mallen-St Clair J; Hamid O; Ho AS; Zumsteg ZS
J Surg Oncol; 2020 Aug; 122(2):254-262. PubMed ID: 32297324
[TBL] [Abstract][Full Text] [Related]
13. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.
Liu C; Rein L; Clarke C; Mogal H; Tsai S; Christians KK; Gamblin TC
J Surg Oncol; 2020 Aug; 122(2):176-182. PubMed ID: 32383268
[TBL] [Abstract][Full Text] [Related]
14. Impact of facility type and volume in low-grade glioma outcomes.
Zhu P; Du XL; Blanco AI; Ballester LY; Tandon N; Berger MS; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Sep; 133(5):1313-1323. PubMed ID: 31561219
[TBL] [Abstract][Full Text] [Related]
15. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
17. Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.
Go RS; Al-Hamadani M; Shah ND; Crowson CS; Holton SJ; Habermann EB
Cancer; 2016 Aug; 122(16):2552-9. PubMed ID: 27182831
[TBL] [Abstract][Full Text] [Related]
18. Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
Amini A; Jones BL; Ghosh D; Schefter TE; Goodman KA
Cancer; 2017 Jan; 123(2):228-236. PubMed ID: 27571233
[TBL] [Abstract][Full Text] [Related]
19. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome.
Kann BH; Park HS; Yeboa DN; Aneja S; Girardi M; Foss FM; Roberts KB; Wilson LD
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):520-526.e2. PubMed ID: 28655598
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.
David JM; Kim S; Placencio-Hickok VR; Torosian A; Hendifar A; Tuli R
Adv Radiat Oncol; 2019; 4(2):302-313. PubMed ID: 31011675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]